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MicroRNAs target specific mRNA(s) to silence its expression and thereby regulate various
cellular processes. We have investigated miRNA gene counts in chromosomes for 20
different species and observed wide variation. Certain chromosomes have extremely high
number of miRNA gene compared with others in all the species. For example, high
number of miRNA gene in X chromosome and the least or absence of miRNA gene in
Y chromosome was observed in all species. To search the criteria governing such variation
of miRNA gene counts in chromosomes, we have selected three parameters- length,
number of non-coding and coding genes in a chromosome. We have calculated Pearson’s
correlation coefficient of miRNA gene counts with length, number of non-coding and
coding genes in a chromosome for all 20 species. Major number of species showed
that number of miRNA gene was not correlated with chromosome length. Eighty five
percent of species under study showed strong positive correlation coefficient (r ≥ 0.5)
between the numbers of miRNA gene vs. non-coding gene in chromosomes as expected
because miRNA is a sub-set of non-coding genes. 55% species under study showed
strong positive correlation coefficient (r ≥ 0.5) between numbers of miRNA gene vs.
coding gene. We hypothesize biogenesis of miRNA largely depends on coding genes, an
evolutionary conserved process. Chromosomes having higher number of miRNA genes
will be most likely playing regulatory roles in several cellular processes including different
disorders. In humans, cancer and cardiovascular disease associated miRNAs are mostly
intergenic and located in Chromosome 19, X, 14, and 1.
Keywords: non-coding gene, miRNA, chromosome, intronic, intergenic, correlation coefficient, coding genes,
disease-association
INTRODUCTION
MicroRNAs are the major key players to regulate the expres-
sion of coding genes (Lagos-Quintana et al., 2001). Genes are
divided into two groups—coding genes that code proteins and
non-coding genes that do not code functional proteins. More
than 98% of human genome is constituted of non-coding DNA
(Elgar and Vavouri, 2008). Recent data from the Encyclopedia
of DNA Elements (ENCODE) project suggests that 80.4% of
the DNA in human genome participates in “at least one bio-
chemical RNA and/or chromatin associated event” (ENCODE
Project Consortium, 2012) implicating the evidence of their reg-
ulatory functions. So, it has been established fact that non-coding
genes can be transcribed to form non-coding RNAs that can play
regulatory role over expression of coding genes. Such non-coding
RNAs are found in all eukaryotes like fungi, plants, protozoans,
and metazoans (Carrington and Ambros, 2003). miRNA is a
sub-set of non-coding RNAs that are transcribed by RNA poly-
merase II to form primary miRNA (Pri-miRNA). Nuclear RNase
III enzyme Drosha and its co-factor process pri-miRNA into 60
nt length precursor miRNA (pre-miRNA) (Chang and Mendell,
2007). The precursor miRNA has stem and loop structure and
it is exported into cytoplasm by exportin 5 followed by cleav-
age with Dicer-TRBP complex to form mature miRNA (Zhang
et al., 2007). This mature miRNAmakes complex with Argonaute
(Ago) proteins to form RNA induced silencing complex (RISC)
(Nasser et al., 2008). The functional strand of miRNA stably asso-
ciated with RISC and the other strand is called passenger strand.
Now the mature miRNA guides the RISC complex to repress its
targets, mainly at 3′-untranslated region (3′-UTR) of mRNA via
short complementary sequence of 6–8 nucleotides (called “seed”
sequence), inducing mRNA destabilization, degradation and/or
inhibiting translation for protein synthesis (Kim, 2005; Nilsen,
2007; Filipowicz et al., 2008; Fabian et al., 2010). One miRNA
can post-transcriptionally silence several 1000 of genes expres-
sions and a single gene can be silenced by more than one miRNA
too (Cui et al., 2006; Wouters et al., 2011). Tissue-specific expres-
sion of miRNA was also observed (Choudhury et al., 2013; Salvi
et al., 2013).
miRNAs can be categorized into four sub-types such as
intergenic (dme-mir-1, mmu-mir-7b, hsa-mir-7-2 etc.), intronic
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(dme-mir-2a-1, mmu-mir-199b, hsa-let-7d etc.), exonic (dme-
let-7, mmu-mir-9-2, hsa-let-7a-2 etc.), and others (dme-mir-
4949, mmu-mir-331, hsa-mir-632 etc.) depending on their
genomic origin (Ying et al., 2010; Chien et al., 2011). miRNA
precursors located in intronic and exonic region of protein
coding gene are called intronic and exonic miRNA respec-
tively. The miRNA precursors located in between two consec-
utive protein coding genes are termed as intergenic miRNA.
The others category includes 3′UTR, 5′UTR and combinations
of any two from intron, exon, 3′UTR and 5′UTR (Griffiths-
Jones et al., 2008; Godnic et al., 2013). Various miRNAs are
produced as per requirement of the cell but the regulation or
detail mechanism(s) of biogenesis of miRNAs are yet to be elu-
cidated. miRNA genes can have transcription start site (TSS)
like the coding genes and transcription factors that are used
for transcription of mRNA are also used for miRNA transcrip-
tion (Aguda et al., 2008; Pichiorri et al., 2010; Wang et al.,
2010a,b). Again, miRNA could also be produced in cell as a by-
product of post-transcriptional processing of coding genes using
splicing machinery and lariat de-branching enzymes bypass-
ing the conventional nuclear miRNA biogenesis pathway by
Drosha cleavage as mentioned above (Okamura et al., 2007;
Flynt et al., 2010). These miRNAs are termed as “Mirtrons”
(Berezikov et al., 2007; Chan and Slack, 2007; Ruby et al.,
2007; Westholm and Lai, 2011; Havens et al., 2012).Therefore,
it is not very clear whether biogenesis of miRNA is a sepa-
rate, parallel process as that of coding gene expression or linked
with it.
Numerous studies to date have established the role of miR-
NAs in diverse cellular processes like stem cell differentiation,
heart development (Chen et al., 2006; Zhao et al., 2007; Ivey
et al., 2008), insulin secretion (Plaisance et al., 2006), apoptosis
(Lukiw and Pogue, 2007; Tarasov et al., 2007), aging (Kumamoto
et al., 2008; Maes et al., 2008), immunity (Chen et al., 2004;
Rodriguez et al., 2007), cell proliferation, metabolism (Hwang
and Mendell, 2007; Taganov et al., 2007; Stefani and Slack, 2008)
etc. Recent studies also revealed that certain miRNAs are strongly
associated with various diseases such as diabetes (Ciccacci et al.,
2013; van de Bunt et al., 2013), cancer (Calin and Croce, 2006;
Blenkiron and Miska, 2007; Wuchty et al., 2012; Benetatos et al.,
2013), cardiovascular disease (Zhao et al., 2005; Sayed et al., 2007;
Zhao et al., 2007), neurodegenerative diseases (Hébert et al., 2008;
Wang et al., 2008a,b) and hence miRNAs can be treated as poten-
tial biomarker or diagnostic tool (Keller et al., 2011; Fassina et al.,
2012; Jones et al., 2012;Weiland et al., 2012; Cuk et al., 2013; Endo
et al., 2013).
There is as such no report available regarding detailed
chromosome-specific localization of miRNA genes or precur-
sors in different species. Here we have extensively studied
the miRNA gene counts in different chromosomes in various
species including human and also collected the miRNAs asso-
ciated with two diseases-cancer and cardiovascular in human
only. We have calculated the correlation coefficient between
miRNA gene counts with chromosome length, number of cod-
ing and non-coding genes in a chromosome and proposed
the evolutionary conserved predominant way of biogenesis of
miRNA.
RESULTS
VARIATION OF miRNA GENE COUNTS IN THE CHROMOSOMES OF
DIFFERENT SPECIES OF METAZOA
We have extensively searched miRBase (Griffiths-Jones et al.,
2008) to locate the miRNA precursors in different chromosomes
and details of karyotype data are collected from Ensembl genome
browser (Flicek et al., 2012) in 20 different species including
human under metazoan. The detail classification of 20 species
under study is shown in Figure 1. We have plotted number of
miRNA precursors vs. chromosome number in all 20 species as
shown in Figures 2A–E. It is evident from those figures that num-
bers of miRNA genes or precursors are widely varied through-
out the all chromosomes of a particular species under study.
Instead, there are certain chromosomes having higher counts of
miRNA precursors ranging from C. elegans to H. sapiens. The
number of miRNA precursors varies from 0 to 161 in a par-
ticular chromosome. For example, the highest number, i.e., 161
miRNA precursors are observed in Chromosome 1 whereas only
2 miRNA precursors are observed in Y chromosome in human.
Chromosome 6 of R. norvegicus has the highest 67 miRNA pre-
cursors out of all the chromosomes but chromosome 16 has only
2 miRNA precursors in the same species. Importantly, the low-
est or no miRNA precursors are observed in Y chromosomes, on
the contrary high number of miRNAs is observed in X chromo-
somes in all the species. This observation suggests that presence of
high number of miRNA genes in X chromosome and the least or
absence of miRNA gene(s) in Y chromosome is an evolutionary
conserved phenomenon. Different species have different number
of chromosomes and the miRNA gene counts in chromosomes
are non-uniform as evident from Figures 2A–E. Furthermore,
we have selected four chromosomes of each species having top
most number of miRNA genes as shown in Table 1 and calculated
percentage of miRNA genes in the said four chromosomes. For
example, Chromosome 1, 2, 4, and 3 are the top most miRNA
genes containing chromosomes of G. gallus in decreasing order
and as high as 39.66% miRNA genes come from these four chro-
mosomes of this species; rest 30 chromosomes contribute ∼60%
miRNA genes.
CORRELATION OF miRNA PRECURSORS WITH CHROMOSOMAL
LENGTH, NUMBER OF CODING/NON-CODING GENES PRESENT IN
RESPECTIVE CHROMOSOMEWITHIN A SPECIES
Different species have different number of chromosomes of
variable length containing variable number of coding and non-
coding genes. We have calculated the correlation coefficients of
miRNA precursor counts with length of chromosome, number of
coding/non-coding genes in all the 20 species as shown in Table 2.
Majority of species (55%) under study showed that miRNA gene
counts were not correlated with the chromosome length. So,
longer chromosomes are not having higher number of miRNA
precursors always. On the contrary, there are certain chromo-
somes in all species where higher number of miRNA genes located
even if the length is shorter than rest of chromosomes and hence
this is an evolutionary conserved event. For example, in M. mus-
culus chromosome 1 (195.47Mbps) is longer than chromosome
2 (182.11Mbps) but the latter has the highest 146 miRNA genes
whereas the earlier has 63 miRNA genes only. Then, we looked
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FIGURE 1 | Species under Metazoa. The detail classification of 20 species (bold) which are chosen in this study.
into the number of coding genes in different chromosomes. It has
been observed that shorter chromosome can have more coding
genes than longer one and maintained through evolution. The
correlation coefficient (r-values, red square) of miRNA precursor
counts with chromosomal length is just following the correla-
tion coefficient (r-values, green square) of coding gene counts vs.
chromosomal length in different species as shown in Figure 3.
This data implicates that chromosomal localization of coding
genes is someway related with that of miRNA genes in all the
species under study.
Further, we calculated correlation coefficient of coding and
non-coding genes with miRNA precursors present in a chromo-
some of all the species as shown in Table 2. The positive corre-
lation has been noticed between miRNA vs. coding gene counts
in all species under study except C. elegans. 55% (75% species
if r ≥ 0.45) of species under consideration shows strong cor-
relation coefficient (r ≥ 0.5) between number of miRNA genes
and coding genes in a chromosome as evident from Table 2.
Eighty five percent of species under consideration shows cor-
relation coefficient (r ≥ 0.5) for miRNA vs. non-coding genes
as expected because miRNA is sub-set of non-coding genes. We
took four species showing r-value less than 0.5 and four species
showing r-value greater than 0.5 and calculated percentage of
each miRNA subtypes out of total miRNA precursors within
the respective species as shown in Table 3. We have observed
that r-value is greater than 0.5 when the sum of intronic and
exonic miRNA precursors is greater than intergenic miRNA pre-
cursors in several species likeH. sapiens, T. guttata, A. carolinensis,
and D. melanogaster. On the contrary, r-value less than 0.5 is
observed when number of intergenic miRNA precursors exceeds
the total of intronic and exonic miRNA counts in species like O.
latipes, S. scrofa, O. anatinus, and G. gorilla as shown in Table 3.
These findings imply that intronic and exonic miRNA genes are
closely related with coding genes in a chromosome and that too
evolutionary conserved.
DIVERSITY OF miRNA SUB-TYPES IN HUMAN CHROMOSOMES
We have observed that miRNA genes are highly concentrated into
certain chromosomes in all the 20 species including human. We
collected total 1876 miRNA precursors from miRBase (Griffiths-
Jones et al., 2008) and categorized them into four groups accord-
ing to their genomic location such as intergenic, intronic, exonic
and others. Chromosome wise variation of sub-types of miRNA
gene counts are given in Figure 4. The four top most inter-
genic miRNA genes containing chromosomes are 19 (14.61%),
X (11.91%), 14 (9.44%), and 1 (5.39%) whereas top most
intronic miRNA genes containing chromosomes are 1 (10.10%),
2 (7.93%), 11 (5.76%), and 3 (5.38%). The exonic miRNA counts
are very less than intergenic and intronic counts in a chromo-
some. We calculated the correlation of miRNA sub-types with
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FIGURE 2 | Continued
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FIGURE 2 | The histogram represents the variation of miRNA precursors
(from miRBase) in different chromosomes of species (A) S. mansoni,
C. elegans, D. melanogaster, C. intestinalis; (B) A. carolinensis, G. gallus,
T. guttata, D. rerio; (C) O. latipes, T. nigroviridis, S. scrofa, O. anatinus;
(D) M. domestica, B. taurus, M. mulatta, P. troglodytes; (E) M. musculus,
R. norvegicus, G. gorilla, H. sapiens.
coding genes. Overall correlation coefficients of coding genes
vs. intergenic, intronic, exonic and others miRNAs are given by
0.47, 0.91, 0.25, and 0.74 respectively, indicating that intronic
and others (3′UTR/5′UTR or combination) miRNA precursors
are strongly correlated with coding genes in human.
miRNAs ASSOCIATED WITH CANCER AND CARDIOVASCULAR
DISEASES IN HUMAN CHROMOSOMES
We collected data of miRNA- disease association from HMDD
v1.0 (January, 2012) which includes 617miRNAs (Lu et al., 2008).
We have categorized the miRNAs that are associated with cancer
and cardiovascular disease separately and searched their location
in chromosomes from miRBase database (Griffiths-Jones et al.,
2008). The variation of counts of miRNA gene associated to the
diseases in different human chromosomes is shown in Figure 5.
We have observed that the counts of disease related miRNA gene
widely varied into all chromosomes as expected but concentrated
in certain chromosomes. Chromosomes 19, X, 14, 1 are the major
cancer-associated miRNA gene containing chromosomes whereas
chromosome 19, 14, 1, X are the major cardiovascular disease-
associated miRNA gene containing chromosomes in decreasing
order. Therefore, all the four chromosomes 19, 14, 1, and X are
the major source of these two disease associated miRNA genes.
Furthermore, we have arranged the miRNAs associated with
cancer and cardiovascular disease according to their genomic ori-
gin like intronic or intergenic using miRBase database resources
and plotted number of miRNA sub-types associated with
cancer (Figure 6A) or cardiovascular disease (Figure 6B) vs.
chromosome number. Bar diagram of Figures 6A,B shows that
disease-associated intronic or intergenic miRNA gene counts
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Table 1 | Percentage of miRNA gene counts in top four highest number of miRNA gene containing chromosomes.
Sl no. Species Total no. of Ch no. Ch no. (2nd Ch no. (3rd Ch no. (4th % miRNA contributed by top
miRNA (A) (highest no. of highest no. of highest no. of highest no. of four highest miRNA gene
miRNA) (B) miRNA) (C) miRNA) (D) miRNA) (E) containing Ch no.
[(B+C+D+E)/A]×100 (%)
1 S. mansoni 19 Ch W(5) Ch 1(5) Ch 5(3) Ch 6(2) 78.94
2 D. melanogaster 236 Ch 2L(53) Ch 2R(52) Ch 3R(52) Ch X(50) 87.71
3 C. elegans 223 Ch X(67) Ch II(41) Ch IV(40) Ch I(27) 78.47
4 C. intestinalis 272 Ch 7(66) Ch 1(43) Ch 3(32) Ch 5(20) 59.19
5 A. carolinensis 156 Ch 2(47) Ch 1(35) Ch 4(22) Ch 3(18) 78.20
6 G. gallus 706 Ch 1(90) Ch 2(73) Ch 4(60) Ch 3(57) 39.66
7 T. guttata 225 Ch 2(25) Ch 1(24) Ch 3(18) Ch Z(16) 36.88
8 D. rerio 347 Ch 4(69) Ch 5(25) Ch 10(21) Ch 23(20) 38.90
9 O. latipes 153 Ch 7(18) Ch 4(18) Ch 14(14) Ch 17(12) 40.52
10 T. nigroviridis 113 Ch 2(10) Ch 1(10) Ch 9(9) Ch 13(9) 33.62
11 S. scrofa 266 Ch X(38) Ch 2(23) Ch 1(20) Ch 12(19) 37.59
12 O. anatinus 106 Ch X1(38) Ch 6(9) Ch 7(9) Ch 1(8) 60.37
13 M. domestica 441 Ch X(143) Ch 2(63) Ch 1(61) Ch 4(40) 69.61
14 M. musculus 1183 Ch 2(146) Ch 12(94) Ch X(90) Ch 11(87) 35.24
15 R. norvegicus 437 Ch 6(67) Ch X(58) Ch 1(49) Ch 10(33) 47.36
16 B. taurus 801 Ch 21(77) Ch X(62) Ch 19(54) Ch 5(52) 30.58
17 M. mulatta 558 Ch 7(79) Ch X(73) Ch 19(58) Ch 1(47) 46.05
18 P. troglodytes 622 Ch X(72) Ch 19(63) Ch 14(59) Ch 1(51) 39.38
19 G. gorilla 327 Ch 14(44) Ch X(43) Ch 1(28) Ch 5(24) 42.51
20 H. sapiens 1876 Ch 1(161) Ch19(142) Ch X(118) Ch 2(113) 28.46
are different in different chromosomes. For example, maximum
intergenic miRNAs associated with both cancer and cardiovascu-
lar diseases are from Chromosome 19 followed by chromosome
14 and X as shown in Figures 6A,B. On the contrary, the highest
number of intronic miRNAs associated with cancer and cardio-
vascular diseases are from chromosome X and 9 respectively.
We calculated the percentages of miRNA sub-types (inter-
genic and intronic) associated with cancer and cardiovascular
disease out of total miRNA precursors of that particular sub-type
(Table 4). We see that 45.84% and 24.26% intergenic miRNAs
are associated with cancer and cardiovascular disease respec-
tively. In a nutshell, higher proportions of inetrgenic miRNAs
are associated with these two diseases compared with intronic
sub-type and their major sources are chromosome 19, 14,
and X.
DISCUSSION
We have investigated variation of miRNA gene counts in all the
chromosomes of 20 different species. To investigate the crite-
ria/logic behind such variation of miRNA gene counts in chromo-
somes, we have selected three parameters such as chromosomal
length, number of coding and non-coding genes present in a
chromosome and evaluated correlation coefficient of miRNA
gene counts with length of chromosome, number of coding and
non-coding genes. We have observed majority (55%) of species
are not following the rule—“higher length chromosome contains
higher number of miRNA genes.” So, length of chromosome is
not only the criteria for chromosomal variation of miRNA gene
counts. Surprisingly, there are certain chromosomes observed in
all the species where the numbers of miRNA gene are extremely
high. In human, Chromosome 1, 19, X, and 2 have high num-
ber of miRNA genes and constitute about 29% of total miRNA
genes. Previously it was shown that miRNAs were non-randomly
distributed in human genome and certain chromosomes had sig-
nificantly higher number of miRNAs than other chromosomes
(Calin et al., 2004). Similar study showed distribution of cancer-
associated miRNAs in mouse genome (Sevignani et al., 2007).
But, we have studied miRNA gene counts in chromosomes in
20 different species and observed certain chromosomes are hav-
ing higher miRNA genes through evolution. For example, X
chromosomes have high number of miRNA genes whereas Y
chromosomes have least or no miRNA gene(s) in all the species.
The reason behind such wide variation of miRNA gene counts in
chromosomes is not clearly understood but this has come up as
an evolutionary conserved phenomenon. It is reported that miR-
NAs are observed to be localized in chromosomes as clusters and
co-expressed all the members from a single polycistronic tran-
script (Guo et al., 2014). The clustered miRNAs are expressed
simultaneously and are involved in a particular pathway or a par-
ticular kind of cellular function. The number of miRNA genes
in a cluster may be as high as 40 and such clustered pattern is
maintained through evolution (Guo et al., 2014). The distribution
of such clusters is again uneven and concentrated in to certain
chromosomes in various species (Chan et al., 2012). For exam-
ple, chromosome X and 14 has 40 and 31 number of clusters of
miRNA in human (Chan et al., 2012). This data is supporting
our observation that chromosome X and chromosome 14 have
higher number of miRNA genes. Possibly, due to this clustering
Frontiers in Genetics | Non-Coding RNA April 2014 | Volume 5 | Article 100 | 6
Ghorai and Ghosh miRNA biogenesis and its implications
Table 2 | Correlation coefficient of number of miRNA precursors vs.
chromosome length, number of coding and non-coding genes in the
respective chromosome.
Sl no. Species Correlation coefficient of number
of miRNA precursors in respective
chromosomes with
Chromosome Coding Non-coding
length genes genes
1 S. mansoni 0.76 0.77 0.62
2 D. melanogaster 0.85 0.85 0.75
3 C. elegans 0.09 −0.37 0.19
4 C. intestinalis 0.54 0.50 0.81
5 A. carolinensis 0.84 0.94 0.92
6 G. gallus 0.97 0.97 0.98
7 T. guttata 0.86 0.79 0.88
8 D. rerio 0.31 0.50 0.92
9 O. latipes 0.22 0.43 0.67
10 T. nigroviridis 0.50 0.47 0.63
11 S. scrofa 0.26 0.41 0.64
12 O. anatinus 0.43 0.46 0.78
13 M. domestica −0.26 −0.15 −0.13
14 M. musculus 0.61 0.70 0.84
15 R. norvegicus 0.46 0.45 0.80
16 B. taurus 0.29 0.45 0.78
17 M. mulatta 0.27 0.55 0.66
18 P. troglodytes 0.26 0.55 0.50
19 G. gorilla 0.31 0.42 0.46
20 H. sapiens 0.53 0.91 0.78
of miRNAwe are getting high concentration of miRNA genes into
certain chromosomes in various species.
Further, we evaluated Pearson’s correlation coefficient between
number of miRNA genes with number of coding and non-coding
genes in a particular chromosome. About 85% species under
study shows strong positive correlation (r ≥ 0.5) for non-coding
genes. One obvious reason is that miRNA is a sub-set of non-
coding RNA and a single primary transcript of non-coding RNA
may produce more than one miRNA (Saini et al., 2007). We
have observed strong positive correlation coefficient (r ≥ 0.5)
between number of miRNA genes and coding genes in a chro-
mosome as evident from Table 2. The relation between expres-
sions of intronic, exonic and others miRNA with protein coding
genes is very close. During the transcription of coding genes
the introns left are used as source of intronic miRNAs. Intronic
miRNAs or mirtrons can be spliced and debranched through
Drosha-independent pathway to produce mature miRNA as
observed in Drosophila (Flynt et al., 2010), nematodes (Ruby
et al., 2007), avians (Glazov et al., 2008), mammals (Berezikov
et al., 2007; Babiarz et al., 2008), and also plants (Zhu et al.,
2008). Lots of reports showed co-expression of intronic miR-
NAs with corresponding host genes (protein coding genes) in
various species, implicating that intronic miRNA and corre-
sponding host protein coding genes are co-transcribed and both
groups are under same regulatory elements such as promoter etc.
FIGURE 3 | Pattern of correlation coefficient of miRNAs and coding
genes with chromosome length. The Pearson correlation coefficient of
miRNAs count and coding genes count with chromosome length of a
species is calculated using Microsoft Office Excel 2003 software and
plotted.
(Lagos-Quintana et al., 2001; Lau et al., 2001; Rodriguez et al.,
2004; Baskerville and Bartel, 2005; Chien et al., 2011). Therefore,
array of mirtrons and host protein coding genes co-localize
in chromosomes and we should get strong positive correlation
between intronic miRNA-coding gene pair. We do get the corre-
lation coefficient value r = 0.91 between intronic miRNA-mRNA
pair in human. Earlier report showed strong positive (r > 0.5)
Pearson’s correlation coefficient of miRNA-mRNA pair in human
using expression data (Wang and Li, 2009). There are reports
where intronic miRNAs can also be transcribed using their own
promoter regions and TSS (Corcoran et al., 2009; Wang et al.,
2010a,b) although major portion of intronic miRNAs are co-
transcribed with host protein coding genes. Similarly, exonic and
others (includes 3′UTR, 5′ UTR and combinations of any two
from intron/exon/3′UTR/5′UTR) miRNA are produced as a by-
product of transcription and post-transcription processing of
coding genes. It is to be noted that we do not check the expression
of miRNAs or coding/non-coding genes but we have calculated
correlation coefficient between miRNA-coding gene pair based
on their chromosome-specific location. We have observed strong
positive correlation (r > 0.5) when summation of intronic and
exonic miRNA exceeds intergenic miRNA while r < 0.5 when
intergenic exceeds the total of intronic and exonic miRNA genes
in a particular species as evident from Table 3. miRNAs under
others category are integral part of protein coding genes and
can be expressed using transcription machinery of coding genes.
Therefore, intronic, exonic and others miRNA genes co-localize
with host protein coding genes through evolution and so there
must be relation between expression of these miRNA genes with
the corresponding coding genes. We hypothesize that intronic,
exonic and others miRNAs are produced as by-product of tran-
scription and post-transcriptional processing of corresponding
host protein coding genes and this is an evolutionary conserved
phenomenon.
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Table 3 | Number of miRNA sub-types in different species.
Species Total miRNA precursors Number of miRNA sub-types (%)
(r-value from Table 2) (under study)
Intergenic % Intronic % Exonic % Others %
H. sapiens (0.87) 1876 445 (23.72) 1059 (56.44) 110 (10.38) 262 (13.96)
T. guttata (0.78) 242 56 (23.14) 34 (14.04) 101 (41.73) 51 (21.07)
A. carolinensis (0.93) 261 88 (33.71) 64 (24.52) 71 (27.20) 38 (14.55)
D. melanogaster (0.85) 236 75 (31.77) 115 (48.72) 21 (8.89) 25 (10.59)
O. latipes (0.42) 164 92 (56.09) 21 (12.80) 41 (25.00) 10 (6.09)
S. scrofa (0.38) 227 109 (48.01) 53 (23.34) 39 (17.18) 26 (11.45)
O. anatinus (0.35) 396 251 (63.38) 106 (26.76) 23 (5.80) 16 (4.04)
G. gorilla (0.41) 317 166 (52.36) 89 (28.07) 29 (9.14) 33 (10.41)
FIGURE 4 | Diversity of miRNA sub-types. The histogram depicts the
variation of number of miRNA sub-types—intergenic, intronic, exonic, and
others in each of the chromosomes of human genome.
Transcription of intergenic miRNAs and its relation with cod-
ing gene expression is poorly understood. Here, we have observed
positive correlation (r = 0.47) between intergenic miRNA vs.
coding genes in humans. The result indicates that expression of
intergenic miRNA is less or no way related with expression of pro-
tein coding genes with compared to intronic miRNAs (discussed
earlier). Previous studies showed that intergenic miRNAs can
have its own promoters for transcription, independent of coding
genes (Saini et al., 2007; Chien et al., 2011). But the promoters
and TSS has similarity with that of coding genes (Corcoran et al.,
2009). Sometimes more than one pre-miRNA may be produced
from the same pri-miRNA transcript, forms cluster miRNAs
(Altuvia et al., 2005), but how exactly intergenic miRNA tran-
scription is related with that of coding gene is not known clearly.
However, RNA polymerase II transcribes miRNA like mRNA and
the same transcription factors are involved in miRNA transcrip-
tion as that of mRNA transcription (Wang et al., 2010a,b).
The chromosomes having high number of miRNA genes are
more crucial for several cellular processes including different dis-
eases. We have observed that the miRNAs associated with cancer
and cardiovascular disorders are concentrated into certain human
FIGURE 5 | Variation of number of miRNAs associated with cancer and
cardiovascular disease in human chromosomes.
chromosomes. An experimental observation showed that miR-
NAs were in cancer-associated genomic regions (CAGR) or in
fragile sites (FRA) in different human chromosomes and certain
chromosomes were found rich with cancer-associated miRNAs
(Calin et al., 2004; Rossi et al., 2008). A statistically signifi-
cant association between chromosomal location of miRNAs and
tumor susceptibility loci was reported in mouse model and such
miRNAs were unevenly distributed in the mouse chromosomes
(Sevignani et al., 2007; Rossi et al., 2008). These findings corrob-
orate our data thatmiRNAs associated with cancer/cardiovascular
disease are unevenly distributed in the human chromosomes and
certain chromosomes have relatively higher disease-associated
miRNA counts like chromosome 19, 14, X, and 1. In other-words,
certain chromosomes are most likely controlling major cellular
processes including the disease onset and progression in differ-
ent species through miRNA. Further, we see that almost 46%
and 24% of total intergenic miRNAs are associated with can-
cer and cardiovascular diseases respectively whereas about 17%
and 6% of total intronic miRNAs are involved in cancer and car-
diovascular diseases. Although the number of intronic miRNAs
is greater than intergenic miRNAs in human, the latter group
contributes larger for these two disease onset and progression.
One possible reason behind this observation could be as follows.
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FIGURE 6 | miRNA sub-types associated with diseases. Counts of intronic and intergenic miRNAs associated with cancer (A) and cardiovascular disease (B)
in different human chromosomes.
Table 4 | Percentage of prevalence of miRNA sub-types associated
with diseases.
Sub-type Total counts Associated with Associated with
of miRNA cancer cardiovascular disease
in human
Total % Total %
miRNAs miRNAs
Intronic 1059 180 16.99 60 5.66
Intergenic 445 204 45.84 108 24.26
Since the clustered miRNAs are mostly involved in any par-
ticular cellular pathway including disease onset/progression etc.
(Willimott and Wagner, 2012; Godnic et al., 2013) and their ori-
gin is mostly from intergenic portion (Chien et al., 2011), and so
we get intergenic miRNAs sub-type is predominantly associated
with cancer and cardiovascular diseases. Since the intronic miR-
NAs are mostly by-product of transcription/post-transcription
processing of corresponding host protein coding genes, one can
look into detailed expression profile of the coding genes which
hosts those disease-associated intronic/exonic/others miRNAs for
better understanding of onset and progression of such diseases.
Furthermore, regulation of biogenesis of miRNAs especially inter-
genic miRNAs will help us to understand some of the molecular
mechanisms of pathogenesis of these two diseases.
MATERIALS AND METHODS
DATA COLLECTION
Details of chromosomal information
We collected the details of each chromosome like length of
the chromosome, number of coding genes and non-coding
genes in that chromosome for 20 different species (Figure 1)
in metazoans from the karyotype data using Ensembl genome
browser (release 74- December 2013), jointly maintained by
European Bioinformatics Institute (EBI) and Welcome Trust
Sanger Institute (WTSI), UK (Flicek et al., 2012). We used the
following Genome assemblies for each species in this work-
ASM23792v1 [S. mansoni], BDGP5 (GCA_000001215.1) [D.
melanogaster], WBcel235 (GCA_000002985.3) [C. elegans], KH
(GCA_000224145.1) [C. intestinalis], AnoCar2.0 (GCA_0000
90745.1) [A. carolinensis], Galgal4 (GCA_000002315.2) [G.
gallus], taeGut3.2.4 [T. guttata], Zv9 (GCA_000002035.2) [D.
rerio], MEDAKA1 [O. latipes], TETRAODON8 [T. nigroviridis],
Sscrofa10.2 (GCA_000003025.4) [S. scrofa], OANA5 (GCF_
000002275.2) [O. anatinus], BROADO5 (GCF_000002295.2)
[M. domestica], GRCm38 (GCA_000001635.4) [M. musculus],
Rnor_5.0 (GCA_000001895.3) [R. norvegicus], UMD3.1 (GCA_
000003055.3) [B. taurus], MMUL_1 [M. mulatta], CHIMP2.1.4
(GCA_000001515.4) [P. troglodytes], gorGor3.1 (GCA_0001
51905.1) [G. gorilla], and GRCh37 (GCA_000001405.14)
[H. sapiens].
Resource for miRNAs
miRBase (Griffiths-Jones et al., 2008) is a vastly used online
registry of miRNAs of a wide range of species focusing on
miRNA nomenclature, annotation and target prediction. We col-
lected information about the chromosomal location of individual
miRNA of a particular species from miRBase (Release 20: June
2013). We also retrieved the details of each miRNAs and catego-
rized them into four groups according to their genomic location
such as intergenic, intronic, exonic and others. We created tables
with columns of chromosome number, chromosome length,
number of coding/non-coding genes and number of miRNAs in
respective chromosomes for each species. We downloaded the
miRNAs associated with cancer and cardiovascular diseases from
HMDD v1.0—a humanmiRNA disease database (Lu et al., 2008).
STATISTICAL ANALYSIS
We calculated Pearson product-moment correlation coefficient
between column of miRNAs with the column of chromosome
length, coding genes and non-coding genes for each species using
Microsoft Office Excel 2003 software.
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